张通.Ivan de Araujo团队揭示GLP-1如何通过肠脑轴神经环路调控机体行为和生理学效应[J].中山大学学报(医学科学版),2023,44(04):718-720.
ZHANG Tong.A New Study From Ivan de Araujo Lab Reported GLP-1 Mediated Gut-Brain Neural Circuit Controls Appetite Suppression[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):718-720.
ZHANG Tong.A New Study From Ivan de Araujo Lab Reported GLP-1 Mediated Gut-Brain Neural Circuit Controls Appetite Suppression[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(04):718-720. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0424.
A New Study From Ivan de Araujo Lab Reported GLP-1 Mediated Gut-Brain Neural Circuit Controls Appetite Suppression
A new study in Cell from Ivan de Araujo and colleagues reported that intestinal GLP-1 acts on an inter-organ sympathetic neural circuit that induces appetite suppression. This study revealed that GLP-1, secreted by ileal L cells, sensing by intestinal myenteric layer intestinofugal neurons activated a sympatho-gastro-spinal-reticular-hypothalamic pathway involved in appetite suppression, linking stomach distention to craniofacial programs for food rejection. These molecularly indentified, delimited enteric circuits may be targeted to ameliorate the abdominal bloating and loss of appetite typical of gastric motility disorders.
关键词
胰高血糖样肽-1厌食肠-脑轴
Keywords
glucagon-like peptide-1anorexiagut-brain axis
references
Han W, Tellez LA, Perkins MH, et al. A neural circuit for gut-induced reward[J]. Cell, 2018, 175(3): 665-678.e23.
Schirra J, Goke B. The physiological role of GLP-1 in human: incretin, ileal brake or more?[J]. RegulPept, 2005, 128(2): 109-115.
Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1[J]. Cell Metab, 2018, 27(4): 740-756.
Eissele R, Goke R, Willemer S, et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man[J]. Eur J Clin Invest, 1992, 22(4): 283-291.
Panaro BL, Yusta B, Matthews D, et al. Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion[J]. Mol Metab, 2020, 37: 100990.
Paternoster S, Falasca M. Dissecting the physiology and pathophysiology of glucagon-like peptide-1[J]. Front Endocrinol (Lausanne), 2018, 9: 584.
Deacon CF. What do we know about the secretion and degradation of incretin hormones?[J]. Regul Pept, 2005, 128(2): 117-124.
Hansen L, Deacon CF, Orskov C, et al. Glucagon-like peptide-1-(7-36) amide is transformed to glucagon-like peptide-1-(9-36) amide by dipeptidyl peptidase Ⅳ in the capillaries supplying the L cells of the porcine intestine[J]. Endocrinology, 1999, 140(11): 5356-5363.
Holst JJ, Andersen DB, Grunddal KV. Actions of glucagon-like peptide-1 receptor ligands in the gut[J]. Br J Pharmacol, 2022, 179(4): 727-742.
D'Alessio D. Is GLP-1 a hormone: whether and when?[J]. J Diabetes Investig, 2016, 7: 50-55.